Inogen Inc (INGN) Stock Analysis
Verdict: WATCH (do not buy)
Stabilizing gross margins and cash reserves offer a floor, but lack of operating leverage delays a rerating until 2029 profitability.
Investment score: 48/100
Analysis as of
Is Inogen Inc stock worth reviewing? The TradeMates thesis
Inogen is a turnaround play with a healthy balance sheet but stalled earnings momentum. The model views the stock as fairly valued at 0.5x sales.
7-factor investment score
- Valuation: 65/100 (weight 20%)
- Financial Health: 45/100 (weight 15%)
- Technical Momentum: 35/100 (weight 15%)
- Earnings Quality: 60/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 55/100 (weight 10%)
- Risk-Adjusted Return: 40/100 (weight 15%)
Inogen Inc opportunities and risks
What speaks for INGN
- Margin Expansion Strategy
What speaks against INGN
- Persistent Operating Losses
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| INGN | n/a | 0.5x | n/a | 48.7% | -7.1% | -6.1% |
| LUCD | n/a | 18.1x | n/a | -40.0% | -876.7% | -50.0% |
| KRMD | n/a | 4.1x | n/a | 61.5% | -5.3% | 0.1% |
| PDEX | 14.8x | 2.3x | 9.5x | 27.8% | 16.1% | 4.0% |
| KRMD | n/a | 4.1x | n/a | 61.5% | -5.3% | 0.1% |
| Peer median | n/a | 4.1x | n/a | 44.6% | -5.3% | 0.1% |
Frequently asked questions about Inogen Inc (INGN)
Is INGN stock a good investment?
The TradeMates model rates Inogen Inc as WATCH (do not buy) with an investment score of 48/100. Inogen is a turnaround play with a healthy balance sheet but stalled earnings momentum. The model views the stock as fairly valued at 0.5x sales. This is algorithmic model output, not personal investment advice.
Is INGN stock a buy?
The TradeMates model verdict for INGN is WATCH (do not buy) with an investment score of 48/100. Treat this as a model signal to review, not a personal buy recommendation.